{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T18:53:39Z","timestamp":1774378419476,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,3,20]],"date-time":"2006-03-20T00:00:00Z","timestamp":1142812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1007\/s00415-005-0020-z","type":"journal-article","created":{"date-parts":[[2006,3,15]],"date-time":"2006-03-15T16:18:42Z","timestamp":1142439522000},"page":"434-440","source":"Crossref","is-referenced-by-count":22,"title":["Diffuse structural and metabolic brain changes in Fabry disease"],"prefix":"10.1007","volume":"253","author":[{"given":"S.","family":"Marino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Borsini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Buchner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mortilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. L.","family":"Stromillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Battaglini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Giorgio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bramanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Federico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Stefano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,3,20]]},"reference":[{"key":"20_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1522-2586(200001)11:1<1::AID-JMRI1>3.0.CO;2-H","volume":"11","author":"Bagley","year":"2000","unstructured":"Bagley LJ, McGowan JC, Grossman RI, Sinson G, Kotapka M, Lexa FJ, et al. (2000) Magnetization transfer imaging of traumatic brain injury. J Magn Reson Imaging 11:1\u20138","journal-title":"J Magn Reson Imaging"},{"key":"20_CR2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ana.10052","volume":"51","author":"Bjartmar","year":"2002","unstructured":"Bjartmar C, Battistuta J, Terada N, Dupree E, Trapp BD (2002) N-acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunohistochemical study on the rat optic nerve. Ann Neurol 51:51\u201358","journal-title":"Ann Neurol"},{"key":"20_CR3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s100720200025","volume":"23","author":"Borsini","year":"2002","unstructured":"Borsini W, Giuliacci G, Torricelli F, Pelo E, Martinelli F, Scordo MR (2002) Anderson- Fabry disease with cerebrovascular complications in two Italian families. Neurol Sci 23:49\u201353","journal-title":"Neurol Sci"},{"key":"20_CR4","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1001\/jama.284.21.2771","volume":"284","author":"Brady","year":"2000","unstructured":"Brady RO, Schiffmann R (2000) Clinical features of and recent advances in therapy for Fabry disease. JAMA 284:2771\u20132775","journal-title":"JAMA"},{"key":"20_CR5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/mrm.1910290605","volume":"29","author":"Brenner","year":"1993","unstructured":"Brenner RE, Munro PM, Williams SC, Bell JD, Barker GJ, Hawkins CP, et al. (1993) The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio. Magn Reson Med 29:737\u2013745","journal-title":"Magn Reson Med"},{"key":"20_CR6","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1212\/WNL.50.6.1746","volume":"50","author":"Crutchfield","year":"1998","unstructured":"Crutchfield KE, Patronas NJ, Dambrosia JM, Frei KP, Banerjee TK, Barton NW, et al. (1998) Quantitative analysis of cerebral vasculopathy in patients with Fabry disease. Neurology 50:1746\u20131749","journal-title":"Neurology"},{"key":"20_CR7","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1161\/01.STR.26.11.2027","volume":"26","author":"de Haan","year":"1995","unstructured":"de Haan R, Limburg M, Bossuyt P, van der Meulen J, Aaronson N (1995) The clinical meaning of Rankin \u2018handicap\u2019 grades after stroke. Stroke 26:2027\u20132030","journal-title":"Stroke"},{"key":"20_CR8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/mrm.1910340511","volume":"34","author":"De Stefano","year":"1995","unstructured":"De Stefano N, Matthews PM, Arnold DL (1995) Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 34:721\u2013727","journal-title":"Magn Reson Med"},{"key":"20_CR9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archneur.58.1.65","volume":"58","author":"De Stefano","year":"2001","unstructured":"De Stefano N, Narayanan S, Francis GS, Arnaoutelis R, Tartaglia MC, Antel JP, et al. (2001) Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 58:65\u201370","journal-title":"Arch Neurol"},{"key":"20_CR10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/13550280009013155","volume":"6","author":"De Stefano","year":"2000","unstructured":"De Stefano N, Narayanan S, Matthews PM, Mortilla M, Dotti MT, Federico A, et al. (2000) Proton MR spectroscopy to assess axonal damage in multiple sclerosis and other white matter disorders. J Neurovirol 6 (Suppl 2):121\u2013129","journal-title":"J Neurovirol"},{"key":"20_CR11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/humu.1380030204","volume":"3","author":"Eng","year":"1994","unstructured":"Eng CM, Desnick RJ (1994) Molecular basis of Fabry disease: mutations and polymorphisms in the human alphagalactosidase A gene. Hum Mutat 3:103\u2013111","journal-title":"Hum Mutat"},{"key":"20_CR12","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1212\/WNL.45.3.478","volume":"45","author":"Filippi","year":"1995","unstructured":"Filippi M, Campi A, Dousset V, Baratti C, Martinelli V, Canal N, et al. (1995) A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 45:478\u2013482","journal-title":"Neurology"},{"key":"20_CR13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(04)15441-X","volume":"363","author":"Fox","year":"2004","unstructured":"Fox NC, Schott JM (2004) Imaging cerebral atrophy: normal ageing to Alzheimer\u2019s disease. Lancet 363:392\u2013394","journal-title":"Lancet"},{"key":"20_CR14","first-page":"36","volume":"92","author":"Grewal","year":"1992","unstructured":"Grewal RP, McLatchey SK (1992) Cerebrovascular manifestations in a female carrier of Fabry\u2019s disease. Acta Neurol Belg 92:36\u201340","journal-title":"Acta Neurol Belg"},{"key":"20_CR15","first-page":"279","volume":"14","author":"Grossman","year":"1994","unstructured":"Grossman RI, Gomori JM, Ramer KN, Lexa FJ, Schnall MD (1994) Magnetization transfer: theory and clinical applications in neuroradiology. Radio Graphics 14:279\u2013290","journal-title":"Radio Graphics"},{"key":"20_CR16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0022-510X(99)00122-7","volume":"166","author":"Hanyu","year":"1999","unstructured":"Hanyu H, Asano T, Sakurai H, Iwamoto T, Takasaki M, Shindo H, et al. (1999) Magnetization transfer ratio in cerebral white matter lesions of Binswanger\u2019s disease. J Neurol Sci 166:85\u201390","journal-title":"J Neurol Sci"},{"key":"20_CR17","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.STR.32.3.643","volume":"32","author":"Iannucci","year":"2001","unstructured":"Iannucci G, Dichgans M, Rovaris M, Bruning R, Gasser T, Giacomotti L, et al. (2001) Correlations between clinical findings and magnetization transfer imaging metrics of tissue damage in individuals with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke 32:643\u2013648","journal-title":"Stroke"},{"key":"20_CR18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1023\/B:BOLI.0000028794.04349.91","volume":"27","author":"Jardim","year":"2004","unstructured":"Jardim L, Vedolin L, Schwartz IV, Burin MG, Cecchin C, Kalakun L, et al. (2004) CNS involvement in Fabry disease: clinical and imaging studies before and after 12 months of enzyme replacement therapy. J Inherit Metab Dis 27:229\u2013240","journal-title":"J Inherit Metab Dis"},{"key":"20_CR19","first-page":"922","volume":"22","author":"Kado","year":"2001","unstructured":"Kado H, Kimura H, Tsuchida T, Yonekura Y, Tokime T, Tokuriki Y, et al. (2001) Abnormal magnetization transfer ratios in normal-appearing white matter on conventional MR images of patients with occlusive cerebrovascular disease. AJNR Am J Neuroradiol 22:922\u2013927","journal-title":"AJNR Am J Neuroradiol"},{"key":"20_CR20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/ana.410230513","volume":"23","author":"Kaye","year":"1988","unstructured":"Kaye EM, Kolodny EH, Logigian EL, Ullman MD (1988) Nervous system involvement in Fabry\u2019s disease: clinicopathological and biochemical correlation. Ann Neurol 23:505\u2013509","journal-title":"Ann Neurol"},{"key":"20_CR21","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/brain\/awf177","volume":"125","author":"Miller","year":"2002","unstructured":"Miller DH, Barkhof F, Frank JA, Parker GJ, Thompson AJ (2002) Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 125:1676\u20131695","journal-title":"Brain"},{"key":"20_CR22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ana.410400105","volume":"40","author":"Mitsias","year":"1996","unstructured":"Mitsias P, Levine SR (1996) Cerebrovascular complications of Fabry\u2019s disease. Ann Neurol 40:8\u201317","journal-title":"Ann Neurol"},{"key":"20_CR23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.brainresbull.2003.09.021","volume":"62","author":"Moore","year":"2003","unstructured":"Moore DF, Altarescu G, Barker WC, Patronas NJ, Herscovitch P, Schiffmann R (2003) White matter lesions in Fabry disease occur in \u2018prior\u2019 selectively hypometabolic and hyperperfused brain regions. Brain Res Bull 62:231\u2013240","journal-title":"Brain Res Bull"},{"key":"20_CR24","first-page":"1096","volume":"24","author":"Moore","year":"2003","unstructured":"Moore DF, Ye F, Schiffmann R, Butman JA (2003) Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease. AJNR Am J Neuroradiol 24:1096\u20131101","journal-title":"AJNR Am J Neuroradiol"},{"key":"20_CR25","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s004150170052","volume":"248","author":"Narayanan","year":"2001","unstructured":"Narayanan S, De Stefano N, Francis GS, Arnaoutelis R, Caramanos Z, Collins DL, et al. (2001) Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b. J Neurol 248:979\u2013986","journal-title":"J Neurol"},{"key":"20_CR26","first-page":"829","volume":"20","author":"Pike","year":"1999","unstructured":"Pike GB, De Stefano N, Narayanan S, Francis GS, Antel JP, Arnold DL (1999) Combined magnetization transfer and proton spectroscopic imaging in the assessment of pathologic brain lesions in multiple sclerosis. AJNR Am J Neuroradiol 20:829\u2013837","journal-title":"AJNR Am J Neuroradiol"},{"key":"20_CR27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/jmri.1880030316","volume":"3","author":"Pike","year":"1993","unstructured":"Pike GB, Glover GH, Hu BS, Enzmann DR (1993) Pulsed magnetization transfer spin-echo MR imaging. J Magn Reson Imaging 3:531\u2013539","journal-title":"J Magn Reson Imaging"},{"key":"20_CR28","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.53.8.1698","volume":"53","author":"Rudick","year":"1999","unstructured":"Rudick RA, Fisher E, Lee JC, Simon J, Jacobs L (1999) Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS.Multiple Sclerosis Collaborative Research Group. Neurology 53:1698\u20131704","journal-title":"Neurology"},{"key":"20_CR29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jns.2004.09.006","volume":"226","author":"Sachdev","year":"2004","unstructured":"Sachdev P (2004) Homocysteine, cerebrovascular disease and brain atrophy. J Neurol Sci 226:25\u201329","journal-title":"J Neurol Sci"},{"key":"20_CR30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0306-4522(91)90101-S","volume":"45","author":"Simmons","year":"1991","unstructured":"Simmons ML, Frondoza CG, Coyle JT (1991) Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45:37\u201345","journal-title":"Neuroscience"},{"key":"20_CR31","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/00004728-200105000-00022","volume":"25","author":"Smith","year":"2001","unstructured":"Smith SM, De Stefano N, Jenkinson M, Matthews PM (2001) Normalized accurate measurement of longitudinal brain change. J Comput Assist Tomograph 25:466\u2013475","journal-title":"J Comput Assist Tomograph"},{"key":"20_CR32","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nimg.2002.1040","volume":"17","author":"Smith","year":"2002","unstructured":"Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A, et al. (2002) Accurate, robust and automated longitudinal and cross-sectional brain change analysis. NeuroImage 17:479\u2013489","journal-title":"NeuroImage"},{"key":"20_CR33","first-page":"916","volume":"24","author":"Takanashi","year":"2003","unstructured":"Takanashi J, Barkovich AJ, Dillon WP, Sherr EH, Hart KA, Packman S (2003) T1 hyperintensity in the pulvinar: key imaging feature for diagnosis of Fabry disease. AJNR Am J Neuroradiol 24:916\u2013921","journal-title":"AJNR Am J Neuroradiol"},{"key":"20_CR34","first-page":"839","volume":"20","author":"Tanabe","year":"1999","unstructured":"Tanabe JL, Ezekiel F, Jagust WJ, Reed BR, Norman D, Schuff N, et al. (1999) Magnetization transfer ratio of white matter hyperintensities in subcortical ischemic vascular dementia. AJNR Am J Neuroradiol 20:839\u2013844","journal-title":"AJNR Am J Neuroradiol"},{"key":"20_CR35","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1212\/WNL.52.8.1663","volume":"52","author":"Tedeschi","year":"1999","unstructured":"Tedeschi G, Bonavita S, Banerjee TK, Virta A, Schiffmann R (1999) Diffuse central neuronal involvement in Fabry disease: a proton MRS imaging study. Neurology 52:1663\u20131667","journal-title":"Neurology"},{"key":"20_CR36","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3171\/jns.1997.87.4.0516","volume":"87","author":"Tedeschi","year":"1997","unstructured":"Tedeschi G, Lundbom N, Raman R, Bonavita S, Duyn JH, Alger JR, et al. (1997) Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 87:516\u2013524","journal-title":"J Neurosurg"},{"key":"20_CR37","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1212\/WNL.60.9.1558-a","volume":"60","author":"van der Flier","year":"2003","unstructured":"van der Flier WM, van Buchem MA, van Buchem HA (2003) Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology 60:1558\u20131559","journal-title":"Neurology"},{"key":"20_CR38","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1212\/WNL.59.6.874","volume":"59","author":"van der Flier","year":"2002","unstructured":"van der Flier WM, van den Heuvel DM, Weverling-Rijnsburger AW, Spilt A, Bollen EL, Westendorp RG, et al. (2002) Cognitive decline in AD and mild cognitive impairment is associated with global brain damage. Neurology 59:874\u2013879","journal-title":"Neurology"},{"key":"20_CR39","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/1531-8249(199911)46:5<747::AID-ANA10>3.0.CO;2-4","volume":"46","author":"van Waesberghe","year":"1999","unstructured":"van Waesberghe JH, Kamphorst W, De Groot CJ, van Walderveen MA, Castelijns JA, Ravid R, et al. (1999) Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 46:747\u2013754","journal-title":"Ann Neurol"},{"key":"20_CR40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(95)91184-7","volume":"345","author":"Vion-Dury","year":"1995","unstructured":"Vion-Dury J, Nicoli F, Salvan AM, Confort-Gouny S, Dhiver C, Cozzone, et al. (1995) Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy (letter). Lancet 345:60\u201361","journal-title":"Lancet"},{"key":"20_CR41","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/jnnp.74.2.213","volume":"74","author":"Walters","year":"2003","unstructured":"Walters RJ, Fox NC, Schott JM, Crum WR, Stevens JM, Rossor MN, et al. (2003) Transient ischaemic attacks are associated with increased rates of global cerebral atrophy. J Neurol Neurosurg Psychiatry 74:213\u2013216","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"20_CR42","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1012993305223","volume":"24","author":"Whybra","year":"2001","unstructured":"Whybra C, Kampmann C, Willers I, Davies J, Winchester B, Kriegsmann J, et al. (2001) Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes. J Inherit Metab Dis 24:715\u2013724","journal-title":"J Inherit Metab Dis"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-005-0020-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-005-0020-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-005-0020-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:03:54Z","timestamp":1559055834000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-005-0020-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,20]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["20"],"URL":"https:\/\/doi.org\/10.1007\/s00415-005-0020-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,20]]}}}